Watanidipine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameWatanidipine
Drug Alias Name伐尼地平vatanidipinevatanidipinovatanidipinumCalbren +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertensionAtherosclerosisStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypertensionAtherosclerosisStroke

Other Information

ATC CodeN/A
Related LinksKEGG